Japan will keep its suspension on the use of the vaccines that prevent meningitis and pneumonia, a health ministry official said after the safety panel’s meeting, but declined to comment further.
The ministry halted the use of Pfizer’s Prevenar and Sanofi’s ActHIB vaccines in response to the deaths of four children shortly after receiving the vaccines.



